Perhaps because of the pandemic, the population has taken a closer look at their health and lifestyle, understanding that being healthy can be the difference between…
In Conversation
The advantage of the company’s general mass spectrometry method is that it can be adapted for a variety of biologics, monoclonal antibodies, vaccines, viral vaccines, gene…
The markets I serve, in particular Africa, will start having exponential growth by the mid-21st century. Demographics, urbanization, technology, investment in infrastructure, and inter-connectivity are all…
There is a huge opportunity ahead for the pharmaceutical industry in Saudi Arabia and for Saudis
It must be remembered that patient empowerment is good for all of us, because all of us could be patients – or caregivers – one day.…
Moving beyond the traditional pharma-government dialogue around payment and access for innovation, we are exploring alternative partnerships with public and private stakeholders to invest in health…
Like many emerging markets, monetary resources are limited in the region, which makes it hard for us considering our high-tech products. Therefore, our strategy has been…
Co-creation based approaches are transforming the way R&D and innovation is being conducted with interactive processes replacing linear processes
Denmark has topped the World Bank’s Ease of Doing Business Index for several years and it is broadly recognized that we have a highly skilled labour…
As a company, we were fortunate to be able to provide advanced healthcare IT systems [during the COVID-19 pandemic] that provided process optimization for users, helping…
Saudi Arabia is the heart of the Arab and Islamic world, an investment powerhouse and the hub connecting continents. Its geographic, cultural, social, demographic, and economic…
After 23 years, we are now building Zealand into a fully integrated independent commercial company and have the right finance, pipeline, and science in place to…
